Post by TUM Venture Labs

Most early-stage startups think about IP too late. Often as protection. Rarely as strategy. In our 31st Expert Session, we shift that perspective. Intellectual property is not just a legal safeguard. It is a business asset that shapes how a company grows, competes, and raises capital. For founders and researchers in #healthcare and #lifesciences, this is especially critical. A well-structured IP approach can define market position, unlock licensing opportunities, and strengthen investor perception. This session focuses on what is practical how to prioritize IP early. How to connect it to business milestones. How to avoid costly mistakes that reduce leverage later. Leading the session is Boris Tchitchanov, patent attorney and partner at HOFFMANN EITLE in Munich. His work sits at the intersection of science, business, and IP strategy, advising companies across the full innovation lifecycle, from portfolio design to litigation and licensing. With a background in chemistry and biochemistry from LMU and ETH Zurich, and experience in medicinal 🔬 chemistry and drug discovery. He brings a perspective grounded in how innovation becomes long term competitive advantage. If you are building in #startups 🚀and thinking about how to protect and scale what you are creating, this session is a strong starting point. The registration link for the session is in the comments below👇